In clinical trials, diosmin decreased the expression of monocytes or neutrophils, and the endothelial activation markers of the intercellular adhesion molecule 1 (ICAM-1) and the vascular cell adhesion molecule 1 (VCAM-1) on human leukocytes in patients with venous ulceration [55]. The gene discussed is VCAM1; the disease is varicose ulcer.